Go to Pathways list
Support our work
DONATE NOW

5th ESO-ESMO-RCE Clinical update on RARE ADULT SOLID CANCERS

Programme
Chairs: J.Y. Blay, FR - P.G. Casali, IT - R. Stahel, CH

The course is an ESO-ESMO-RCE joint event

                      

In partnership with           In collaboration with  

The “ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers” is an educational effort held on an annual basis and conceived to strengthen the education of medical professionals willing to devote their career to rare cancers. 
Despite being rare as single entities, rare adult solid cancers account for as many as 15% of all new cancer cases, thus being the main group within rare cancers in general. The definition of rare cancers by the RARECARE project and the list of the 10 “families” of rare adult solid cancers gave rise to shape the sessions of this course: 

- Head & neck cancers
- Sarcomas
- Rare thoracic tumors
- Neuroendocrine tumors
- Central nervous system neoplasms
- Rare female genital cancers
- Endocrine gland tumors
- Digestive rare cancers
- Rare urological and male genital tumors
- Rare skin cancers & non-cutaneous melanoma

Since ‘networking’ and ‘multidisciplinarity’ are the two main keywords to improve the quality of care of rare cancers, ESO has decided to develop the programme of this course in collaboration with other the European initiatives in this field and to give its contribution to tackle the rare cancer issue. The 5th ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers is conceived in the context of, and supported by, EURACAN, the European Reference Network on rare adult solid cancers. The Faculty has been largely selected from EURACAN, also with the aim of letting this educational effort closely interact with its networking activities.
 
Optimal management of rare adult solid cancers poses specific diagnostic and therapeutic challenges. The sessions of the course have been designed to address the needs of clinical oncologists wanting an update on recent advancements on these tumours.

The global health crisis caused by the Covid-19 pandemic has forced us to turn the in-person course into a virtual event. It will be a good opportunity to receive updates on the available evidence in this field and promote future networking and collaborations.
 
We have done our best to design an online course enabling participants to attend according to their own schedule. There will be a mixture of pre-recorded sessions and live sessions for Q & A and clinical case discussions with faculty members and moderators.

Paolo Casali
On behalf of the co-Chairs


INFORMATION
The course will be carried out in two different steps:
Step 1
Pre-recorded sessions will be made available from 1st December 2020 and will remain on the e-eso website. You will be able to see all the sessions in your own time, and send questions that will be selected for discussion during Step 2 of the course;
Step 2
Live sessions with an introductory round table on rare cancers in general, clinical case presentations and Q&A discussions with moderators and speakers will be held on 16 and 17 January 2021.
During the Q&A sessions, speakers will answer and discuss a number of selected questions received in advance via email (see below for instructions) and/or during the live streaming via chat.

Q&A SESSIONS

Participants are encouraged to send questions in advance, as long as they listen to the recorded sessions. The moderators will select questions to be answered during the live streaming. Questions should be sent to raretumours@eso.net, no later than 4 January 2021. Please indicate the session title and speaker your question refers to.

All the contents will be recorded and accessible via the e-ESO website after the event (registration to access the contents will remain open).

IDEAL PARTICIPANT'S PROFILE
- Medical degree
- Specialization/residency in medical oncology, radiation oncology, surgical oncology or equivalent
 
LEARNING OBJECTIVES
Provide an update on the latest developments in the area of rare adult solid rare cancers, with a background perspective on  state-of-the-art and evidence based practice.

REGISTRATION
Registration for the course is required but free (link below).
Registration will be confirmed by e-mail.

OFFICIAL LANGUAGE
The official language is English. Translation will not be provided. 
 
CME ACCREDITATION CERTIFICATES
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certficate that will be issued by email. 
Application for CME recognition has been submitted to the Accreditation Council of Oncology in Europe (ACOE) and 24 CME credits have been granted to this event. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
 
ESCO CREDITS
The Course enables ESCO students to earn ESCO credits and therefore access more ESCO benefits. Full and active participation in the Course earns participants 22 ESCO credits.
Visit www.esco.org for information on how to join ESCO.

ORGANISING SECRETARIAT
Marina Fregonese - Event Organiser - mfregonese@eso.net
Dolores Knupfer - Event Organiser - dknupfer@eso.net
Mariachiara Deleo - e-ESO Assistant - mdeleo@eso.net
Francesca Marangoni - e-ESO Executive Manager - fmarangoni@eso.net  

Follow us on FacebookTwitter and Instagram: #e_ESO

Click HERE to view the course brochure

Instructions on how to use e-ESO to participate in this event 

The course will remain available until JANUARY 2022.

Programme

16.01.2021

Moderator: Fedro Alessandro Peccatori

Moderator: Rolf A. Stahel

Introduction

Expert: Fedro Alessandro Peccatori

Expert: Rolf A. Stahel

Round table: The Rare Cancer Agenda 2030

Expert: Jean-Yves Blay

Expert: Paolo Giovanni Casali

Expert: Francesco De Lorenzo

Expert: Kathy Oliver

Expert: Fedro Alessandro Peccatori

Expert: Annalisa Trama

Q&A and general discussion

Expert: Jean-Yves Blay

Expert: Paolo Giovanni Casali

Expert: Francesco De Lorenzo

Expert: Kathy Oliver

Expert: Fedro Alessandro Peccatori

Expert: Rolf A. Stahel

Expert: Annalisa Trama

16.01.2021

Moderator: Marina Garassino

Moderator: Rolf A. Stahel

Q&A

Expert: Rolf A. Stahel

Expert: Marina Garassino

Clinical case discussion

Presenter: Giulia Galli

16.01.2021

Moderator: Paolo Giovanni Casali

Moderator: Jean-Yves Blay

Q&A

Expert: Paolo Giovanni Casali

Expert: Jean-Yves Blay

Expert: Silvia Stacchiotti

Expert: Alessandro Gronchi

Expert: Sandra Strauss

Clinical case discussion

Expert: Anna Maria Frezza

16.01.2021

Moderator: Vincent Gregoire

Moderator: Lisa Licitra

Q&A

Expert: Cesare Piazza

Expert: Vincent Gregoire

Expert: Lisa Licitra

Expert: Laura Deborah Locati

Expert: Christian Simon

Expert: Loris De Cecco

Clinical case discussion

Expert: Carlo Resteghini

16.01.2021

Moderator: Martyn Caplin

Moderator: Filippo De Braud

Q&A

Expert: Nicola Fazio

Expert: Filippo De Braud

Expert: Martyn Caplin

Clinical case discussion

Presenter: Giulia Arrivi

16.01.2021

Moderator: Riccardo Soffietti

Moderator: Martin J. Van den Bent

Q&A

Expert: Riccardo Soffietti

Expert: Martin J. Van den Bent

Expert: Judith Balmana

Clinical case discussion

Presenter: Alessia Pellerino

17.01.2021

Moderator: Christelle de la Fouchardiere

Moderator: Lisa Licitra

Q&A

Expert: Alfredo Berruti

Expert: Jaume Capdevila

Expert: Lisa Licitra

Expert: Christelle de la Fouchardiere

Expert: Silvia Franceschi

Clinical case discussion

Presenter: Elena Colombo

17.01.2021

Moderator: Lucjan Wyrwicz

Moderator: Filippo De Braud

Q&A

Expert: Robert Glynne-Jones

Expert: Marcello Deraco

Expert: Filippo De Braud

Expert: Lucjan Wyrwicz

Expert: Heinz-Josef Klumpen

Clinical case discussion

Expert: Monica Niger

17.01.2021

Moderator: Jourik A. Gietema

Moderator: Andrea Necchi

Q&A

Expert: Tit Albreht

Expert: Jourik A. Gietema

Expert: Ruth Ladenstein

Expert: Andrea Necchi

Clinical case discussion

17.01.2021

Moderator: Michael Seckl

Moderator: Fedro Alessandro Peccatori

Q&A

Expert: Isabelle Ray-Coquard

Expert: Fedro Alessandro Peccatori

Expert: Michael Seckl

Expert: Domenica Lorusso

Clinical case discussion

Presenter: Stefanie Aust

17.01.2021

Moderator: Ellen Kapiteijn

Moderator: Sophie Piperno-Neumann

Q&A

Expert: Celeste Lebbé

Expert: Stefano Cavalieri

Expert: Martina Angi

Expert: Sophie Piperno-Neumann

Expert: Ellen Kapiteijn

Clinical case discussion

Presenter: Thais Tong

Closing remarks

Expert: Paolo Giovanni Casali

Top